Over Prescription Drugs Case Study

442 Words1 Page

Unregulated price control on prescription medications has led parametrical companies to overprice drug treatments. The increase in cancer drug prices in the last 15 years has many contributing factors and is harming our patients and our health care system.1 Supporting government intervention to lower the price of prescription medications can solve the unreasonable priced cancer drug treatments. On the other half, it may bring a downward spiral in our innovations in research and development for new treatments. Today drugs represent a monopoly, taking thousands of dollars from out of pocket pay from cancer patients. The financial burden of cancer treatment would be $20,000 to 30,000 a year, nearly half of the average annual household income in the United States.1 Its also said that patients with cancer pay 50% to 100% more for the same patented drug than other countries.1 Several drugs that prolong life by years while another by days are priced the same.1This is unfair to patients, if they are unaware of these types of drugs. Most cancers are not curable, and most approved cancer drugs work only for a limited time. 2 They are only beneficial for a short period so why price overprice them? …show more content…

Many patients discontinue with their drug treatments due to them being highly priced.1 Regulated drug price control may benefit the public but not so much for the economy. The revenues and profits that companies make are used mainly to advertise new drug treatments and fund clinical research. Pharmaceutical companies spend only 1.3% of their revenues on basic research.1 This make no sense that only a small portion is used for research while the rest is spent on marketing. Price controlling may reduce marketing and advertising on new drugs, which may in return produce low revenues and profits for the company. Then we ask ourselves, what matters most the people or

Open Document